BioFish Holding AS

As of March 31, 2025, BioFish Holding AS has 111.98M shares outstanding.

These figures are as of March 31, 2025. The price-to-sales ratio is 2.20, and the price-to-book ratio stands at 0.77.

These figures are as of March 31, 2025. The EV/Sales ratio of 3.09 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. BioFish Holding AS trades at an EV/FCF ratio of 11.48, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of March 31, 2025, BioFish Holding AS maintains a current ratio of 0.91, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.60, indicating elevated leverage, while an interest coverage ratio of -1.56 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2025, BioFish Holding AS posted a negative return on equity (ROE) of -10.21, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -7.34, reflecting losses generated across the asset base. Return on capital employed (ROCE) is negative at -1.30, pointing to unprofitable operations over the period. Inventory turnover of 3.67 indicates how many times BioFish Holding AS sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on August 8, 2025, BioFish Holding AS's stock has gained approximately 46.67% over the past 52 weeks. The 50-day moving average sits at 1.74, while the 200-day moving average is 1.41.

Over the twelve months ended March 31, 2025, BioFish Holding AS posted a gross margin of 35.59, reflecting its pricing power and cost economics. The operating margin of -18.51 and net profit margin of -30.35 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2025. Free cash flow yield stands at 6.84, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -9.64, meaning BioFish Holding AS raised more capital through share issuance and new debt than it returned via dividends and buybacks.

BioFish Holding AS's most recent stock split took place on January 13, 2023 with a 1000:1457 split ratio.

As of March 31, 2025, BioFish Holding AS has an Altman Z-Score of 1.11, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.